Genor Biopharma Holdings Limited (HK:6998) has released an update.
Genor Biopharma Holdings Limited has announced a Board meeting scheduled for August 28, 2024, to review and approve the company’s interim financial results for the first half of the year. This significant meeting for stakeholders will discuss the performance of the company and its subsidiaries up until June 30, 2024. The announcement was made by the CEO and Chairman, Dr. Guo Feng, underlining the importance of the event for investors and market watchers.
For further insights into HK:6998 stock, check out TipRanks’ Stock Analysis page.